155 related articles for article (PubMed ID: 21571861)
1. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma.
Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H
Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models.
Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y
Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747
[TBL] [Abstract][Full Text] [Related]
3. RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers.
Futami K; Furuichi Y
Front Genet; 2014; 5():441. PubMed ID: 25620975
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
5. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase.
Futami K; Kumagai E; Makino H; Goto H; Takagi M; Shimamoto A; Furuichi Y
Cancer Sci; 2008 Jan; 99(1):71-80. PubMed ID: 17953710
[TBL] [Abstract][Full Text] [Related]
6. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
[TBL] [Abstract][Full Text] [Related]
9. RECQL1 plays an important role in the development of tongue squamous cell carcinoma.
Tao J; Tao S; Han J; Zhou Z; Zhang X; Wang H; Chen R; Ji F; Zhu Y
Cell Physiol Biochem; 2014; 33(5):1579-90. PubMed ID: 24854846
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
[TBL] [Abstract][Full Text] [Related]
11. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase.
Futami K; Takagi M; Shimamoto A; Sugimoto M; Furuichi Y
Biol Pharm Bull; 2007 Oct; 30(10):1958-61. PubMed ID: 17917271
[TBL] [Abstract][Full Text] [Related]
12. [Application of novel clinicopathological biomarkers].
Chano T
Rinsho Byori; 2012 Feb; 60(2):167-73. PubMed ID: 22568098
[TBL] [Abstract][Full Text] [Related]
13. Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line.
Mriouah J; Boura C; Pinel S; Chretien AS; Fifre A; Merlin JL; Faivre B
Int J Oncol; 2010 Dec; 37(6):1555-63. PubMed ID: 21042725
[TBL] [Abstract][Full Text] [Related]
14. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of WRN helicase by external guide sequence and RNase P RNA.
Hitrik A; Abboud-Jarrous G; Orlovetskie N; Serruya R; Jarrous N
Biochim Biophys Acta; 2016 Apr; 1859(4):572-80. PubMed ID: 26808708
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
Xu L; Yeudall WA; Yang H
Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
[TBL] [Abstract][Full Text] [Related]
18. Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.
Schafer JM; Peters DE; Morley T; Liu S; Molinolo AA; Leppla SH; Bugge TH
PLoS One; 2011; 6(5):e20532. PubMed ID: 21655226
[TBL] [Abstract][Full Text] [Related]
19. The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines.
Park SW; Kim HS; Choi MS; Kim JE; Jeong WJ; Heo DS; Sung MW
Anticancer Drugs; 2011 Jun; 22(5):416-23. PubMed ID: 21301321
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells.
Lo WL; Chien Y; Chiou GY; Tseng LM; Hsu HS; Chang YL; Lu KH; Chien CS; Wang ML; Chen YW; Huang PI; Hu FW; Yu CC; Chu PY; Chiou SH
Biomaterials; 2012 May; 33(14):3693-709. PubMed ID: 22361100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
